Lupin launches generic Prucalopride tablets for chronic idiopathic constipation in the US market, a bioequivalent to Takeda's ...

Lupin receives USFDA approval for its generic version of Prucalopride tablets, used to treat chronic idiopathic constipation ...

Lupin launches Prucalopride tablets in US for chronic constipation treatment, bioequivalent to Motegrity, with estimated ...

Lupin has received USFDA approval for its ANDA for Prucalopride Tablets, used to treat Chronic Idiopathic Constipation in ...

Mumbai: Global pharma major Lupin Limited has launched Prucalopride Tablets, 1 mg, and 2 mg, in the United States, following ...

This product, bioequivalent to Motegrity Tablets of Takeda Pharmaceuticals, will be manufactured at Lupin's Goa facility in ...

Lupin receives FDA approval for Prucalopride Tablets to treat chronic idiopathic constipation, bioequivalent to Motegrity.

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.

With the weight-loss blockbuster drug Wegovy, now in India, renowned endocrinologist and diabetologist Dr. Ambrish Mithal ...

Lupin has launched Prucalopride tablets in the US following USFDA approval. The bowel disorder treatment enters a $184 ...

A WOMAN who was left feeling depressed because of her weight has shared the transformation she has had with Mounjaro. Terri ...

Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...